Cookies managing
We use cookies to provide the best site experience.
Cookies managing
Cookie Settings
Cookies necessary for the correct operation of the site are always enabled.
Other cookies are configurable.
Essential cookies
Always On. These cookies are essential so that you can use the website and use its functions. They cannot be turned off. They're set in response to requests made by you, such as setting your privacy preferences, logging in or filling in forms.
Analytics cookies
Disabled
These cookies collect information to help us understand how our Websites are being used or how effective our marketing campaigns are, or to help us customise our Websites for you. See a list of the analytics cookies we use here.
Advertising cookies
Disabled
These cookies provide advertising companies with information about your online activity to help them deliver more relevant online advertising to you or to limit how many times you see an ad. This information may be shared with other advertising companies. See a list of the advertising cookies we use here.
Pharmaceutical, Biotech and Medical device Companies
/
/
Pharmaceutical, Biotech and Medical device Companies
For decades clinical trials data has been the gold standard for decision making in healthcare. However, this practice is currently changing towards increased use of the real world data.
This shift is helping us to better understand the unmet medical needs, patient journey, define marketing strategy, support clinical decisions and more.
Value Based Healthcare (VBHC) solutions to assess patient outcomes
WHO reports that almost 10% of global GDP is spent on healthcare. So how to measure efficiency of this expenditure? Value based healthcare concept that is centered at the patients’ outcomes is one of the probable answers. It is the wide spread of EMR and EHR systems and resulted accumulation of real world data that really brings VBHC to life and allows to provide in depth analysis of treatments value.
Regulatory decision-making support
Now regulators around the world start recognizing the potential and importance of this data for regulatory questions at hand. Growing reliability and relevance of RWD allows it to become a vital instrument in consideration for both pre- and post-market decisions.
Market access strategies
Access to real world data can help understand current situation in specific geographies of interest regarding disease prevalence, treatment and prescription patterns. Traverse platform allows for regular updates with understanding campaign dynamics.
Personalized medicine
RWD can be used to identify genetic and molecular markers that predict response to drugs, which can be used to personalize treatment options.
See also
Healthcare providers
CROs
Drug discovery & beyond
Healthtech
/
/
Pharmaceutical, Biotech and Medical device Companies
Have a study in mind?
We are here to help you to lead the cutting edge studies and leverage RWD to answer your research questions
get in touch
Schedule a capabilities call with a member of our team today and get your personal solution
TRAVERSE
Türkiye
İçerenköy Mah. Kayışdağı Cad. Acıbadem Üniversitesi Tip Fakültesi C Blok, No: 32-36c Ataşehir/İstanbul, Türkiye
© 2024
The Netherlands
Fred. Roeskestraat 115, 1076 EE, Amsterdam, Netherlands
Explore RWD